Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A sham injection is a placebo intervention used in clinical research to simulate a therapeutic injection without delivering an active pharmacological agent. In the context of the trial conducted by Haydarpasa Numune Training and Research Hospital (NCT07174167), the sham injection consisted of 6 mL of 0.9% saline administered to the knee region, specifically avoiding the genicular nerves. This procedure serves as a control to differentiate the physiological and psychological effects of the injection process (placebo effect) from the specific therapeutic effects of genicular nerve blocks using local anesthetics like prilocaine or corticosteroids like triamcinolone in patients with chronic knee osteoarthritis. All participants in the sham group also followed a standardized daily knee exercise program to ensure a consistent baseline of care.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sham injection.